abstract |
Briefly described, embodiments of the present disclosure include compounds, pharmaceutical compositions, methods of treating a host infected with a virus from the Flaviviridae virus, methods of inhibiting HCV replication in a host, HCV minus strand RNA in a host Methods of inhibiting NS4B polypeptide binding to the 3 ′ UTR, methods of treating liver fibrosis in a host, and the like. |